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Abstract
Background: Excitatory amino acid toxicity, oxidative stress, intracellular calcium overload, as well as inflammation and 
apoptosis are involved in the pathological process after cerebral ischemic reperfusion injury. Picrodide 2 could inhibit 
neuronal apoptosis and play anti-oxidant and anti-inflammation role in cerebral ischemia/reperfusion injuries, but the 
exact mechanism is not very clear. This study aims to explore the anti-inflammation mechanism of picroside 2 in 
cerebral ischemic reperfusion injury in rats.
Methods: The middle cerebral artery occlusion reperfusion models were established with intraluminal thread 
methods in 90 adult healthy female Wistar rats. Picroside 2 and salvianic acid A sodium were respectively injected from 
tail vein at the dosage of 10 mg/kg for treatment. The neurobehavioral function was evaluated with Bederson's test 
and the cerebral infarction volume was observed with tetrazolium chloride (TTC) staining. The apoptotic cells were 
counted by in situ terminal deoxynucleotidyl transferase-mediated biotinylated deoxyuridine triphosphate nick end 
labeling (TUNEL) assay. The immunohistochemistry stain was used to determine the expressions of toll-like receptor 4 
(TLR4), nuclear transcription factor κB (NFκB) and tumor necrosis factor α (TNFα). The concentrations of TLR4, NFκB and 
TNFα in brain tissue were determined by enzyme linked immunosorbent assay (ELISA).
Results: After cerebral ischemic reperfusion, the rats showed neurobehavioral function deficit and cerebral infarction 
in the ischemic hemisphere. The number of apoptotic cells, the expressions and the concentrations in brain tissue of 
TLR4, NFκB and TNFα in ischemia control group increased significantly than those in the sham operative group (P < 
0.01). Compared with the ischemia control group, the neurobehavioral scores, the infarction volumes, the apoptotic 
cells, the expressions and concentrations in brain tissue of TLR4, NFκB and TNFα were obviously decreased both in the 
picroside 2 and salvianic acid A sodium groups (P < 0.01). There was no statistical difference between the two 
treatment groups in above indexes (P > 0.05).
Conclusions: Picroside 2 could down-regulate the expressions of TLR4, NFκB and TNFα to inhibit apoptosis and 
inflammation induced by cerebral ischemic reperfusion injury and improve the neurobehavioral function of rats.
Background
Excitatory amino acid toxicity, oxidative stress, intracel-
lular calcium overload, as well as inflammation and apop-
tosis, are involved in the pathological process after
cerebral ischemic reperfusion injury[1]. Among these, the
inflammatory cytokines activate nuclear transcription
factor κB (NFκB) through toll-like receptor 4 (TLR4)-
NFκB signal transduction pathways, promote target gene
activation, such as tumor necrosis factor α (TNFα), inter-
leukin (IL), intercellular adhesion molecule (ICAM), and
ultimately induce neuronal apoptosis[2,3]. Picrorhiza
scrophulariflora belongs to the plant family composed of
picroside 1, 2 and 3, of which picroside 2 is one of the
most effective components extracted from the dried rhi-
zome and roots of Picrorhiza kurrooa Royle ex Benth[4]
and Picrorhiza scrophulariae flora Pennell [5]. It has been
traditionally used to treat disorders of the liver, upper
respiratory tract diseases, dyspepsia, chronic diarrhea
and scorpion sting[5,6]. Current researches on picroside
2 are focused on its neuroprotective[7], anti-apoptotic,
anti-cholestatic, anti-oxidant, anti-inflammation, immu-
nemodulating activities[8,9]. It has been confirmed that
picroside 2 could enhance nerve growth factor-induced
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Page 2 of 7PC12 cell axon growth, reduce H2O2 induced PC12 cell
damage and improve cell survival in vitro [10-13]. Animal
experiments showed that the extractive of Picrorhizae
could inhibit cell apoptosis in ischemic penumbra and
improve neurobehavioral function in middle cerebral
artery occlusion and reperfusion (MCAO/R) rats[14,15].
Our previous experiments[16-19] indicated that picro-
side 2 could inhibit the expressions of inducible nitric
oxide synthase (iNOS), nuclear transcription factor κB
(NFκB) and inhibitor of NFκB (IκB), and reduce the
expressions of Caspase-3 and poly ADP-ribose poly-
merase (PARP) to inhibit the neuronal apoptosis and thus
improve the neurobehavioral function of rats with cere-
bral ischemia reperfusion injury. However, it is poorly
understood that how many ingredients there are in the
extract Picrorhizae and which one can play physiological
role. In the study, we established the experimental
MCAO/R model to investigate the effects of picroside 2
via tail vein injection on TLR4-NFκB signal transduction
pathway and cell apoptosis, and to explore its anti-
inflammatory mechanism in cerebral ischemic reperfu-
sion injury.
Methods
Establishment of animal models
The total of 90 adult female Wistar rats, weight 230 - 250
g, SPF grade, were granted by Qingdao Laboratory Ani-
mal Center (SCXK (LU) 20030010). The guidance sugges-
tions for care of laboratory animals was followed
according to the Guidelines for caring for experimental
animals published by the Ministry of Science and Tech-
nology of the People's Republic of China. All animals
were reared in the laboratory environment, allowed free
access to food and water in room temperature and
humidity-controlled housing with natural illumination
for a week, and fasted 12 h before operation. Fifteen rats
were randomly selected as a sham operated group (SO),
and the rest 75 rats were subjected to the experimental
middle cerebral artery occlusion 2 h and reperfusion 22 h
(MCAO/R) models with intraluminal monofilament
suture from left external-internal carotid artery [20,21].
At 2 h after the operation, those with left Horner sign,
right anterior limb flexible or circling towards right, were
considered as symbols of successful models. Core body
temperature was monitored with a rectal probe and
maintained at 36°C-37°C using a homeothermic blanket
control unit (Qingdao Apparatus, China) during and after
the surgery operation. As a result, 45 successful models,
as the candidate, were randomly divided into a ischemia
control group (IC, n = 15), a salvianic acid A sodium
group (SA, n = 15) and a picroside treated group (PT, n =
15) according to drug administration. Rats in the SO
group were experimented with the same surgical proce-
dure but the monofilament was advanced only about 10
mm and immediately withdrew. The 30 dead or unsuc-
cessfully occluded rats were excluded from this experi-
ment.
Intervention study
According to the Pharmacopoeia of the People's Republic
of China, the molecular formula of picroside 2 is
C23H28O13, molecular weight is 512.48; the molecular for-
mula of salvianic acid A sodium is C9H9O5Na, molecular
weight is 221.17. The chemical structure formulae[22] are
shown as figure 1:
Picroside 2 (Tianjin Kuiqing Medical Technology Co.
Ltd., CAS No: 39012-20-9, purity > 98%), as a treatment
drug, was diluted into 1% injection with 0.1 mol/L PBS,
and salvianic acid A sodium (Shanghai Huyun Medical
Technology Co. Ltd., CAS No: 23028-17-3, purity > 98%)
was also diluted into 1% solution as a positive control
drug. According to Xiao's report [23], the rats in PT
group were administrated picroside 2 (10 mg/kg) 250 μl
via tail vein at ischemia 2 h prior to reperfusion with a
micro-syringe. Rats in SA group were given salvianic acid
A sodium (10 mg/kg) 250 μl, while those in IC group and
SO group were simultaneously suffered 0.1 mol/L PBS
250 μl.
Neurobehavioral function assessment
All animal neurobehavioral tests were performed at isch-
emia 2 h and reperfusion 22 h by an investigator who was
blinded to the experiment according to the standard of
Bederson's report[24]. 0 score: no neurological functional
Figure 1 The chemical structure formula of picroside 2 (left) and salvianic acid A sodium (right).
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Page 3 of 7impairment; 1 score: any part of forepaw flexed (positive
for tail suspension test) without other abnormal signs; 2
scores: lateral pushing resistance ability decreased (posi-
tive for lateral pushing experiment), accompanied with
forepaw flexion without circling tendency; 3 scores: same
behavior as those for 2 scores, in addition to spontaneous
rotation (circling around paralyzed limbs during free
activity). The higher the score is gotten, the worse the
neurobehavioral dysfunction is appeared, vice versa.
TTC staining
To determine the infarction volume, five rats in each
group were deeply anesthetized by 10% chloral hydrate
(300 mg/kg) and decapitated at given time after MCAO/
R. The brain tissue was removed and successivelly sliced
into 2.0 mm-thick coronal sections. The total of five brain
slices were incubated in 2% TTC solution for 10 min at
37°C and then transferred into 4% formaldehyde solution
for fixation. The normal brain tissue appeared uniform
red while the infarction region showed white. The infarc-
tion volumes were calculated in a blinded manner with
Adobe PhotoShop CS analysis system. The data were
expressed as the percentage of the infarction volume/the
ipsilateral hemisphere volume (%) at the coronal section
of optic chiasma.
Neuronal apoptosis assay
Five rats in each group were deeply anesthetized by 10%
chloral hydrate (300 mg/kg), reperfused with sodium
chloride and 4% formaldehyde 200 ml from the heart into
the aorta, and then decapitated at given time. Brain sam-
ples were chosen from frontal fontanelle 2 mm to occipi-
tal fontanelle 4 mm by a stereotaxic point, post-fixed in
4% formaldehyde for 2 h, dehydrated in alcohol gradually,
hyalinized by dimethylbenzene, embedded in paraffin,
then sectioned at a thickness of 5 μm, adhered to the sec-
tions prepared with poly-L-Lysine, and finally stored at
4°C. To detect cell apoptosis, TUNEL staining was per-
formed according to the protocol of DendEnd Fluoro-
metric TUNEL Detection System (Santa Cruz Co. Ltd.).
Coronal paraffin sections described as above were depar-
affinaged by dimethylbenzene, hydrated by gradient etha-
nol and washed by distilled water. Some sections added
DNase I at a dose of 1 μg/ml were regarded as positive
control sample, and those treated without TdT were the
negative ones. Under a 400-fold immunofluorescent
microscope (wavelength 488 nm), the apoptotic cells
were appeared yellow-green fluorescence in nucleus, and
averaged in four random views in cortex and striatum,
respectively.
Immunohistochemical staining
Rabbit anti-rat TLR4, NFκB and TNFα moloclonal anti-
body (1:100) were purchased from Santa Cruz Co. Ltd.
Strept-avidin-biotin complex (SABC) immunohisto-
chemistry kit, diaminobenzidine (DAB) dye were granted
by Bostor biological company in Wuhan China. Paraffin-
embedded sections were deparaffinaged in dimethylben-
zene, hydrated successively in gradient ethanol, restored
antigen twice in a microwave oven. Immunohistochemi-
cal procedures were performed strictly according to the
guidance of manufacture. Under a microscope, those
with brown granules in cytoplasm or nucleus were con-
sidered as positive cells. And the slides added 0.1 mmol/L
PBS (containing 1:200 non-immunity animal serum)
instead of primary antibody had no response. Four serial
sections were chosen from each experimental rat and
observed randomly four views at cortex and striatum
under a 400-fold microscope. Absorbance values (A) of
each view was detected by a LEICA Qwin microgramme
analytical system (Leica company).
Enzyme linked immunosorbent assay (ELISA)
Rat TLR4 (No. E02T0013), NFκB p65 (No. E02N0014)
and TNFα (No. E02T0012) ELISA kits were purchased
from Blue Gene Co. Ltd. Five rats in each group were
deeply anesthetized and decapitated at given time after
MCAO/R. The ischemic hemisphere tissue (0.5 g) was
quickly removed and ground fully into brain tissue homo-
genate. Then added normal sodium 500 μl, mixed well
and centrifugalized for 10 minutes at 12000 r/min. The
upper limpid liquid was collected and stored at -20°C
(Avoid repeated freeze-thaw cycles). Prepare all stan-
dards before starting assay procedure. First, secure the
desired number of coated wells in the holder, then add 50
μl of standards or samples to the appropriate well of the
antibody pre-coated microtiter plate. Add 100 μl of con-
jugate to each well. Mix well, cover and incubate for 1 h at
37°C. Wash the microtiter plate 5 times using distilled or
de-ionized water. Add 50 μl substrate A & B to each well.
Cover and incubate for 15 minutes at 25°C. Add 50 μl of
stop solution to each well. Mix well and calculate the
mean absorbance value A450 for each set of reference
standards and samples. The standard density is a X, the
B/B0 is a Y, sitting to mark the paper in the logit-log up
draw a standard curve. According to the B/B0 that need
to be measured the sample can from sit to mark the den-
sity value that the paper looks up the sample up. The sen-
sitivity by this assay is 1.0 pg/ml (TLR4 and TNFα) and
1.0 ng/ml (NFκB).
Statistical Analysis
SPSS11.5 software was used for statistical analysis. Data
were expressed as mean ± standard error (  ± s). Multi-
group comparison was made by analysis of variance
(ANOVA) and Student's test, and two-group comparison
x
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is less than 0.05.
Results
Neurobehavioral dysfunction score
There was no neurobehavioral dysfunction symptom in
rats of the SO group, whose Bederson's score got 0 points.
After cerebral ischemia/reperfusion injury, all animals
showed neurobehavioral dysfunction. The Bederson's
scores both in the SA group and PT group were obviously
lower than that in the IC group (F = 24.90, q = 8.38-8.88,
P < 0.01). The scores in PT group is slightly lower than
that in SA group, but no significant difference was found
between these two groups (t = 0.50, P > 0.05). Shown as
table 1.
The cerebral infarction volume
By TTC stain, no cerebral ischemia infarction was shown
in the brain slices of the SO group, while infarction lesion
almost appeared in all the experimental rats after cerebral
ischemic reperfusion injury. The volume of cerebral
infarction in the SA group and PT group were signifi-
cantly lower than that in the IC group (F = 30.76, q =
8.66-10.33, P < 0.01), but there is no statistical difference
between the SA group and PT group (t = 1.66, P > 0.05).
Shown as table 1 and figure 2.
Neuronal apoptosis
A few apoptotic cells were scattered in the cortex and the
striatum in SO group rats. Apoptotic cells were signifi-
cantly increased in the IC group. As we expected, the
number of apoptosis both in the SA group and PT group
were obviously low compared with the IC group (F =
29.05, q = 4.03-12.84, P < 0.01), but no difference existed
between the SA group and PT group (t = 0.49, P > 0.05).
Shown as table 1 and figure 3.
The expressions of TLR4, NFκB and TNFα
With the help of immunohistochemistry, we found that
there were no region differences between the cortex and
the striatum. Thus we calculated the absorbance values
(A) in four confirmed views instead of the random ones
in each brain slice.
Few TLR4 positive cells with light yellow granules could
be seen in the cortex and the striatum in SO group rats,
and its expression was very weak. TLR4 expression in IC
group was significantly elevated along with the increased
A value as compared with the SO group rats; After the
drug administration, the A values in the SA group and PT
group were obviously decreased in contrast to the IC
group rats (F = 4.33, q = 2.95-4.92, P < 0.05). Although the
A value in the SA group was slightly lower than that in the
PT group, there was no significant differences between
the two treatment groups, suggesting that picroside 2
could inhibit the expression of TLR4 protein and play
neuroprotective effects as same as salvianic acid A
sodium (t = 1.31, P > 0.05). Shown as table 2 and figure 4.
Weak NFκB expression were shown in the cortex and
the striatum in SO group rats. The number of NFκB posi-
tive cells rapidly increased, and its A value was signifi-
cantly higher than that in the SO group; the expression of
NFκB both in the SA group and PT group were appar-
ently lower than that in the IC group (F = 14.25, q = 6.24-
8.17, P < 0.01), but there was no difference between the
SA group and PT group as shown in table 2 and figure 5 (t
= 0.64, P > 0.05).
Ditto, the TNFα expression was very weak in the cortex
and the striatum in SO group rats. TNFα positive cells
was clearly increased in the IC group, and its A value was
significantly higher than that in the SO group; the A val-
ues in the SA and PT groups were obviously low com-
pared with the IC group (F = 6.39, q = 3.42-6.03, P < 0.05),
and there was no difference between the SA group and
the PT group, too (t = 0.81, P > 0.05). Shown as table 2
and figure 6.
The concentrations in brain tissue of TLR4, NFκB and TNFα
The concentrations in brain tissue of TLR4, NFκB and
TNFα were lowly in SO group rats, and increased signifi-
Table 1: Bederson's score, infarction volume and apoptotic cells (  ± s)
Groups Bederson's score(n = 15) Infarction volume(n = 5) Apoptotic cells (n = 5)
SO group 0.00 ± 0.00 0.00 ± 0.00 3.53 ± 1.13
IC group 2.17 ± 0.35Δ 77.32 ± 3.06Δ 16.62 ± 3.25Δ
SA group 1.33 ± 0.43* 70.11 ± 3.13* 8.13 ± 2.15*
PT group 1.28 ± 0.38*# 68.73 ± 3.46*# 7.64 ± 2.08*#
ΔP < 0.01, vs the SO group; * P < 0.01, vs the IC group; # P > 0.05, vs the SA group.
x
Figure 2 The cerebral infarction volume shown by TTC stain (A. 
SO group, B. IC group, C. SA group, D. PT group).
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group, the concentrations of TLR4 (F = 79.42, q = 7.20-
21.43, P < 0.01), NFκB (F = 111.25, q = 7.98-25.27, P <
0.01) and TNFα (F = 95.29, q = 6.89-23.27, P < 0.01) were
obviously lower than those in the IC group, but there was
no difference between the SA group and PT group (t =
170, 1.01, 1.69, P > 0.05). Shown as table 3.
Discussion
TLR4 is a member of signal transduction family, which
combines with the adapter protein MyD88 and then with
interleukin-associated kinase (IRAKs) to cause NFκB
translocation, to enable the innate immune and inflam-
matory responses related gene transcription, to activate
the TLR4-MyD88 dependent signal transduction path-
way and to induce inflammatory response[1]. Caso et al
[2] found that the cerebral infarction volume in TLR4
deficient rats was smaller than that in normal TLR4 ani-
mals after middle cerebral artery occlusion and reperfu-
sion. Hua et al [25] proved that cerebral infarction size in
TLR4 knockout mice was also smaller than the wild-type
ones, and its neurological deficit score was lower accord-
ingly. The studies of Yang et al [26] showed that the TLR4
positive lymphomonocytes in blood circulation signifi-
cantly elevated in patients with acute cerebral infarction
as compared with that in the control group and the
patients with transient ischemic attack, and the expres-
sion levels of TLR4 mRNA and TNFα in serum were con-
sistent with IL6. From the data of correlation analysis,
they further found that TLR4 and serum cytokine expres-
sion levels were closely related to the severity of stroke.
Thus they speculated it is TLR4 that activates the down-
stream signaling protein, evokes the gene transcription
associated with the encoding and inflammation-related
factor, induces and aggravates the inflammatory
response.
NFκB is an important nuclear transcription factor in
eukaryotic cells, which exists in almost all the cells. It is
located downstream of TLR signaling pathway, regulated
by TLRs and involved in immune response and the pro-
cesses of cell proliferation and differentiation. Cerebral
ischemic reperfusion injury not only promotes the innate
immune response of the immune system, but also acti-
vates TLR4-mediated signal transduction pathway to rap-
idly translocate NFκB from cytoplasm into nucleus, and
combines with specific DNA sequence to stimulate
downstream-associated factor (TNFα)-induced inflam-
mation response and ischemia neuronal apoptosis[27].
With the application of MCAO models, Lou et al [28]
confirmed that the increased TNFα protein and its
mRNA expression and NFκB DNA-binding-activity
could reduce the survival number of spinal cells in the
hippocampal CA1 area, suggesting that NFκB activation
can lead to neuronal apoptosis in inflammation following
cerebral ischemic reperfusion injury. It will become a new
treatment target to reduce cerebral ischemic reperfusion
injury through efficiently decreasing TNFα protein and
mRNA expression and inhibiting NFκB DNA binding-
activity. Liu et al [29] reperted that the expression of
NFκB enhanced in cytoplasmic or nuclear in brain slices,
and the use of Oxymatrine decreased the NFκB expres-
sion and the infarction lesions in rats with permanent
middle cerebral artery occlusion compared with the sham
operation group. Webster et al [30] found that hypo-
thermy could attenuate the NFκB inhibition factor (IκB)
phosphorylation and IκB suppressor kinase, and decrease
the expression of NFκB, thereby protect neurons in pen-
umbra against focal ischemic reperfusion damage. The
data of Zhang et al [31] have demonstrated that the
Figure 3 Apoptosis in cortex shown by TUNEL × 200 (A. SO group, 
B. IC group, C. SA group, D. PT group).
 
Table 2: Absorbance values of TLR4, NFκB and TNFα expressions (  ± s)
Groups n TLR4 NFκB TNFα
SO group 5 0.16 ± 0.09 0.14 ± 0.07 0.14 ± 0.08
IC group 5 0.46 ± 0.18Δ 0.65 ± 0.21Δ 0.51 ± 0.17Δ
SA group 5 0.28 ± 0.13* 0.26 ± 0.15* 0.30 ± 0.16*
PT group 5 0.24 ± 0.13*# 0.22 ± 0.08*# 0.25 ± 0.12*#
ΔP < 0.01, vs the SO group; * P < 0.01, vs the IC group; # P > 0.05, vs the SA group.
x
Figure 4 TLR4 expression in cortex shown by SABC × 400 (A. SO 
group, B. IC group, C. SA group, D. PT group).
  
Guo et al. Behavioral and Brain Functions 2010, 6:43
http://www.behavioralandbrainfunctions.com/content/6/1/43
Page 6 of 7intracerebroventricular administration of prostaglandin
after cerebral ischemia could inhibit the expression of
subunit NFκB and play the protection role in ischemia
neurons. These results intimate that the inhibition of
NFκB expression to reduce apoptosis may be one of the
mechanisms to improve the brain ischemic reperfusion
injury. Our previous researches proved that picroside 2
could inhibit the expressions of iNOS [16], NFκB and
IκB[17], and reduce the expressions of Caspase-3,
PARP[18] and to inhibit the neuronal apoptosis and thus
improve the neurological function of rats with cerebral
ischemia reperfusion injury[19]. It also reduced brain tis-
sue edema and the aquaporin-4 (AQP4) expression, and
the best therapeutic time window was 1 h after cerebral
ischemic reperfusion [32].
This experiment showed that slight expressions of
TLR4, NFκB and TNFα could be seen in the cortex and
the striatum in the SO group, and their concentrations in
brain tissue were very lowly. After cerebral ischemia 2 h
and reperfusion 22 h, the expressions of these proteins, as
well as the TUNEL-positive cells and concentrations in
brain tissue increased significantly in contrast to the SO
group. The data imply that the activation of TLR4 and its
downstream NFκB inflammatory factor induce neuronal
apoptosis and cerebral ischemic reperfusion injury. In
this experiment, NFκB protein inactively expressed in
cytoplasm in the SO group. After cerebral ischemic rep-
erfusion, it mainly located in nuclear, suggesting that the
activation of NFκB into nucleus promote the expression
of the downstream target genes TNFα, be involved in
inflammatory response and induce neuronal apoptosis.
Accordingly, the experimental animals appeared cerebral
infarction lesions, abnormal morphology and the
increased neuronal apoptosis in ischemic ipsilateral, and
neurobehavioral dysfunction in contralateral hemisphere.
We also found that the injection of picroside 2 and salvi-
anic acid A sodium via tail vein significantly reduced the
amount of apoptotic cells, the concentrations in brain tis-
sue and the expressions of TLR4, NFκB and TNFα pro-
teins in the cortex and the striatum in MCAO/R rats,
together with the decreased infarction size and the
improvement of cellular structure and neurobehavioral
function of rats. In short, the neuroprotective effect of
picroside 2 and salvianic acid A sodium against cerebral
ischemic reperfusion injury might be performed by
inhibiting TLR4-NFκB signal transduction pathway to
reduce inflammatory response-induced apoptosis. How-
ever, the concrete differences between the two Chinese
drugs needs to further elucidated.
Conclusion
Picroside 2 could down-regulate the expressions of TLR4,
NFκB and TNFα to inhibit apoptosis and inflammation
induced by cerebral ischemic reperfusion injury and
improve the neurobehavioral function of rats.
List of abbreviations used
MCAO/R: middle cerebral artery occlusion/reperfusion;
SO group: sham operated group; IC group: ischemia con-
trol group; SA group: salvianic acid A sodium group; PT
group: picroside treated group; TTC: tetrazolium chlo-
ride; TLR4: toll-like receptor 4; NFκB: nuclear transcrip-
tion factor κB; TNFα: tumor necrosis factor α; TUNEL:
terminal deoxynucleotidyl transferase-mediated biotiny-
lated deoxyuridine triphosphate nick end labelling;
SABC: strept-avidin-biotin complex; DAB: diaminobenz-
idine; ELISA: enzyme linked immunosorbent assay.
Figure 5 NFκB expression in cortex shown by SABC × 400 (A. SO 
group, B. IC group, C. SA group, D. PT group).
 
Figure 6 TNFα expression in cortex shown by SABC × 400 (A. SO 
group, B. IC group, C. SA group, D. PT group).
  
Table 3: The concentrations in brain tissue of TLR4, NFκB and TNFα (  ± s)
Groups n TLR4 NFκB TNFα
SO group 5 14.26 ± 2.08 11.53 ± 2.13 12.34 ± 2.25
IC group 5 62.45. ± 7.26Δ 75.16 ± 9.12Δ 67.78 ± 8.37Δ
SA group 5 34.28 ± 5.04* 39.23 ± 4.38* 35.16 ± 4.71*
PT group 5 30.45 ± 4.32*# 31.64 ± 4.46*# 28.76 ± 4.03*#
ΔP < 0.01, vs the SO group; * P < 0.01, vs the IC group; # P > 0.05, vs the SA group.
x
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